Becton Dickinson (BDX) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Becton Dickinson (BDX) Net Income towards Common Stockholders Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 17.38% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -282.67% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -25.78% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 9.23% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 56.71% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -188.83% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 20.94% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -96.77% |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | -7.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -282.67% |
| Dec 31, 2025 | 26.07% |
| Sep 30, 2025 | 23.25% |
| Jun 30, 2025 | 17.86% |
| Mar 31, 2025 | -72.07% |
| Dec 31, 2024 | 7.83% |
| Sep 30, 2024 | 270.37% |
| Jun 30, 2024 | 24.23% |
| Mar 31, 2024 | 22.60% |
| Dec 31, 2023 | -42.18% |
| Sep 30, 2023 | -59.25% |
| Jun 30, 2023 | 15.98% |
| Mar 31, 2023 | 1.62% |
| Dec 31, 2022 | -25.80% |
| Sep 30, 2022 | 9.50% |
| Jun 30, 2022 | -32.67% |
| Mar 31, 2022 | 55.60% |
| Dec 31, 2021 | -33.23% |
| Sep 30, 2021 | 130.48% |
| Jun 30, 2021 | 81.23% |